Recall
FDAHealthDecember 12, 2025

Merck Sharp & Dohme LLC — Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nord

⚠️ Presence of particulate matter: potential presence of metal particulates in the product.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
December 12, 2025

Nationwide in the USA

What's affected?

Product
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Brand
EMEND
Lot code
Z014503

Additional details

Lot #: Z014503, Exp 11/15/2027

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 3 - single dose kits.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.